SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 76 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,352,386 | -49.0% | 1,151,425 | -9.7% | 0.00% | -50.0% |
| Q2 2023 | $8,538,855 | +525691.6% | 1,274,456 | +411.0% | 0.00% | +300.0% |
| Q1 2023 | $1,624 | +501.5% | 249,412 | +686.8% | 0.00% | – |
| Q4 2022 | $270 | -100.0% | 31,701 | -90.9% | 0.00% | -100.0% |
| Q3 2022 | $1,844,000 | -4.4% | 349,280 | -23.2% | 0.00% | 0.0% |
| Q2 2022 | $1,929,000 | -51.3% | 455,051 | -23.6% | 0.00% | -50.0% |
| Q4 2021 | $3,964,000 | -58.4% | 595,259 | -37.6% | 0.00% | -66.7% |
| Q3 2021 | $9,518,000 | +3311.5% | 953,691 | +10461.4% | 0.01% | – |
| Q2 2021 | $279,000 | -82.6% | 9,030 | -75.4% | 0.00% | -100.0% |
| Q1 2021 | $1,603,000 | -79.2% | 36,752 | -77.9% | 0.00% | -83.3% |
| Q4 2020 | $7,694,000 | – | 166,039 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 1,910,029 | $12,721,000 | 3.35% |
| Orbimed Advisors | 8,740,887 | $58,214,000 | 0.75% |
| Nantahala Capital Management | 1,006,462 | $6,703,000 | 0.24% |
| EcoR1 Capital, LLC | 1,060,010 | $7,060,000 | 0.22% |
| Prosight Management, LP | 53,815 | $358,000 | 0.21% |
| RA Capital Management | 1,742,186 | $11,603,000 | 0.20% |
| Endurant Capital Management LP | 84,295 | $561,000 | 0.14% |
| HighVista Strategies LLC | 22,434 | $149,000 | 0.12% |
| XTX Topco Ltd | 18,816 | $125,000 | 0.07% |
| WASATCH ADVISORS LP | 1,773,690 | $11,813,000 | 0.05% |